nafamostat has been researched along with Delayed Hypersensitivity in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwaki, M | 1 |
| Oda, M | 1 |
| Ozeki, M | 1 |
| Ino, Y | 1 |
| Suzuki, K | 1 |
| Koshiyama, Y | 1 |
| Motoyoshi, A | 1 |
| Ogihara, M | 1 |
| Suzuki, S | 1 |
| Fujita, M | 1 |
1 other study available for nafamostat and Delayed Hypersensitivity
| Article | Year |
|---|---|
[Pharmacological studies of FUT-175, nafamstat mesilate. III. Anti-inflammatory activities of FUT-175].
Topics: Animals; Anti-Inflammatory Agents; Arthus Reaction; Benzamidines; Capillary Permeability; Chemotaxis | 1984 |